Galera Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Galera Therapeutics, Inc. reported Earnings Per Share Diluted of $0.64 per share for the year ending 2025.

  • Galera Therapeutics, Inc. showed an increase of +288.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Galera Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Galera Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 148.1%.
  • Historical annual values: Fiscal year 2025: $0.64 per share | Fiscal year 2024: $0.34 (loss) per share | Fiscal year 2023: $1.33 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: